Cardiac protection by volatile anaesthetics: A review

Current Vascular Pharmacology

Volumn 6, Issue 2, 2008, Pages 108-111

  Landoni, Giovanni ^a   Fochi, Oliviero ^a   Torri, Giorgio ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Anaesthesia; Desflurane; Meta analysis; Mortality; Myocardial infarction; Sevoflurane; Volatile anaesthetics

Indexed keywords

DESFLURANE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; SEVOFLURANE; TROPONIN I; DRUG DERIVATIVE; ETHER DERIVATIVE; ISOFLURANE; TROPONIN;

ANESTHESIA INDUCTION; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG INDICATION; DRUG MECHANISM; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; ISCHEMIC PRECONDITIONING; LENGTH OF STAY; MORTALITY; REVIEW; THROMBOCYTE ADHESION; ANIMAL; BLOOD; DRUG EFFECT; HEART; HEART INFARCTION PREVENTION; INTENSIVE CARE; PATHOPHYSIOLOGY;

ANESTHETICS, INHALATION; ANIMALS; CORONARY ARTERY BYPASS; HEART; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; LENGTH OF STAY; METHYL ETHERS; MYOCARDIAL INFARCTION; TROPONIN;

EID: 47249097088     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016108783955284     Document Type: Review

References (40)

1. Landoni G, Biondi-Zoccai GGL, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, et al. Desflurane and Sevoflurane in cardiac surgery. A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007; 21(4): 502-11.
2. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97(3): 623-33.
3. Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leao P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39(5): 967-75.
4. Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107(14): 1848-51.
5. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74(5): 1124-36.
6. Warltier DC, al-Wathiqui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988; 69(4): 552-65.
7. Cason BA, Gamperl AK, Slocum RE, Hickey RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997; 87(5): 1182-90.
8. Chiari P, Bouvet F, Piriou V. [Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications]. Ann Fr Anesth Reanim 2005; 24(4): 383-96.
9. Varadarajan SG, An J, Novalija E, Stowe DF. Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(2+) loading in intact hearts. Anesthesiology 2002; 96(1): 125-33.
10. Ross S, Foex P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999; 82(4): 622-32.
11. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999; 91(5): 1437-46.
12. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thamer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81(6): 905-12.
13. Riess ML, Kevin LG, Camara AK, Heisner JS, Stowe DF. Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts. Anesthesiology 2004; 100(3): 569-74.
14. Ludwig LM, Patel HH, Gross GJ, Kersten JR, Pagel PS, Warltier DC. Morphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology 2003; 98(3): 705-11.
15. Kato R, Foẍ P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anesth 2002; 49(8): 777-791.
16. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR. Is isoflurane-induced preconditioning dose related? Anesthesiology 2002; 96(3): 675-80.
17. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 2005; 100(6): 1584-93.
18. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M, Inserte J, Agullo L, Cabestrero A. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion. Cardiovasc Res 2006; 70(2): 274-85.
19. Novalija E, Varadarajan SG, Camara AK, An J, Chen Q, Riess ML, et al. Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 2002; 283(1): H44-52.
20. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70(2): 181-90.
21. Hu G, Vasiliauskas T, Salem MR, Rhone DP, Crystal GJ. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. Anesthesiology 2003; 98(3): 712-8.
22. Mobert J, Zahler S, Becker BF, Conzen PF. Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology 1999; 90(5): 1372-81.
23. Heindl B, Becker BF, Zahler S, Conzen PF. Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts. Acta Anaesthesiol Scand 1998; 42(8): 995-1003.
24. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 2002; 96(1): 183-8.
25. Das DK, Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc Res 2006; 70(2): 254-63.
26. Foex P. Inhalation anaesthesia and myocardial preconditioning. Minerva Anestesiol 2003; 69(6): 483-94.
27. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004; 62(1): 74-85.
28. De Hert SG. The concept of anaesthetic-induced cardioprotection: clinical relevance. Best Pract Res Clin Anaesthesiol 2005; 19(3): 445-59.
29. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100(19 Suppl): II340-4.
30. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003; 98(6): 1315-27.
31. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, et al. Cardiac protection by volatile anaesthetics: a multi-centre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007; 24(4): 323-31.
32. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006; 20(4): 477-83.
33. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101(2): 299-310.
34. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97(1): 42-9.
35. Tuman KJ, McCarthy RJ, Spiess BD, DaValle M, Dabir R, Ivankovich AD. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 1989; 70(2): 189-98.
36. Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2006; 20(4): 493-502.
37. De Hert SG. Anesthetic preconditioning: how important is it in today's cardiac anesthesia? J Cardiothorac Vasc Anesth 2006; 20(4): 473-6.
38. Landoni G, Calabro MG, Marchetti C, Bignami E, Scandroglio AM, Dedola E, et al. Pharmacological preconditioning in patients undergoing mitral surgery with or without concomitant ischemic disease. J Cardiothorac Vasc Anesth 2007; 21(5): 672-7.
39. Yu C, Beattie WS. Ischemic preconditioning with volatile anesthetics in CABG: a meta-analysis. Can J Anaesth 2005; 52: A27.
40. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006; 97(2): 127-136.